---
title: "BIOLIGHT released its performance for the first three quarters, with a net loss attributable to the parent company of 8.3417 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262667968.md"
description: "According to the Zhitong Finance APP, BIOLIGHT released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 793 million yuan, a year-on-year decrease of 1.77%. The net loss attributable to shareholders of the listed company was 8.3417 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 29.1406 million yuan. The basic loss per share was 0.0315 yuan"
datetime: "2025-10-24T16:25:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262667968.md)
  - [en](https://longbridge.com/en/news/262667968.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262667968.md)
generator: "portal-rs"
---

# BIOLIGHT released its performance for the first three quarters, with a net loss attributable to the parent company of 8.3417 million yuan

According to the Zhitong Finance APP, BIOLIGHT (300246.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 793 million yuan, a year-on-year decrease of 1.77%. The net loss attributable to shareholders of the listed company was 8.3417 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 29.1406 million yuan. The basic loss per share was 0.0315 yuan

### Related Stocks

- [300246.CN](https://longbridge.com/en/quote/300246.CN.md)

## Related News & Research

- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)
- [Cell C publishes pro forma financials after Comm Equipment Company merger](https://longbridge.com/en/news/296585930.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [Ata Turizm Discloses High Non-Compliant Income Under Participation Finance Rules](https://longbridge.com/en/news/296522750.md)
- [REG - Ceiba Investments Ld - Notice of an Order of the Royal Court of Guernsey](https://longbridge.com/en/news/296354077.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**